Volume 25 - Issue 10 - October 2017

A recent study evaluated a new anti-inflammatory drug for the treatment of patients with active psoriatic arthritis.
John D. Peters, MD, and Jason S. Ballin, DO
Alexander Dane, DO, FAAD; Raimundo Gonzales, MD; and Arlene Rogachefsky, MD, FAAD
Anita Arthur, MPH; Kurt A. Ashack, MD; Amor Khachemoune, MD, FAAD, FACMS
Jennifer Winter, MSPAS, PA-C; and Kristen Grippe, MPAS, PA-C
Jo-David Fine, MD, MPH, FRCP, and Ron J. Feldman, MD, PhD

Reuters

Homepage Highlight